Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

DNA-PK/Chk2 induces centrosome amplification during prolonged replication stress

Abstract

The antineoplastic drug hydroxyurea (HU), when used at subtoxic doses, induces prolonged replication stress and centrosome amplification. This causes genomic instability and increases the malignancy of the recurring tumor. The mechanism of centrosome amplification induced by prolonged replication stress, however, is still unclear. Here, we examined the involvement of ataxia telangiectasia, mutated (ATM), ataxia telangiectasia, mutated and Rad3-related (ATR) and DNA-dependent protein kinase (DNA-PK) and found that HU-induced centrosome amplification was inhibited by the depletion of DNA-PKcs, but not ATM and ATR. Inactivation of ATM/ATR in U2OS cells instead caused aneuploidy and cell death. We found DNA-PKcs depletion also abrogated ATM phosphorylation, indicating that ATM activation during prolonged replication stress depends on DNA-PK. Depletion of DNA-PK abrogated checkpoint kinase (Chk)2 activation and partially reduced Chk1 activation. Chk2 depletion blocked HU-induced centrosome amplification, indicating a function of Chk2 in centrosome amplification. We further found that Chk2 was phosphorylated at Thr68 on the mother centriole at late G2 and mitosis when unstressed and on all amplified centrioles induced by HU. In summary, we have elucidated that DNA-PK/Chk2 signaling induces centrosome amplification upon long-term HU treatment, therefore increasing our insight into tumor recurrence after initial chemotherapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Stehman FB, Bundy BN, Kucera PR, Deppe G, Reddy S, O'Connor DM . Hydroxyurea 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group. Gynecol Oncol 1997; 66: 262–267.

    Article  CAS  Google Scholar 

  2. Prosser SL, Straatman KR, Fry AM . Molecular dissection of the centrosome overduplication pathway in S-phase-arrested cells. Mol Cell Biol 2009; 29: 1760–1773.

    Article  CAS  Google Scholar 

  3. Khodjakov A, Rieder CL, Sluder G, Cassels G, Sibon O, Wang CL . De novo formation of centrosomes in vertebrate cells arrested during S phase. J Cell Biol 2002; 158: 1171–1181.

    Article  CAS  Google Scholar 

  4. Sato N, Mizumoto K, Nakamura M, Ueno H, Minamishima YA, Farber JL et al. A possible role for centrosome overduplication in radiation-induced cell death. Oncogene 2000; 19: 5281–5290.

    Article  CAS  Google Scholar 

  5. Bennett RA, Izumi H, Fukasawa K . Induction of centrosome amplification and chromosome instability in p53-null cells by transient exposure to subtoxic levels of S-phase-targeting anticancer drugs. Oncogene 2004; 23: 6823–6829.

    Article  CAS  Google Scholar 

  6. Durocher D, Jackson SP . DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme? Curr Opin Cell Biol 2001; 13: 225–231.

    Article  CAS  Google Scholar 

  7. Shiloh Y . ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003; 3: 155–168.

    Article  CAS  Google Scholar 

  8. Bakkenist CJ, Kastan MB . DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003; 421: 499–506.

    Article  CAS  Google Scholar 

  9. Stiff T, Walker SA, Cerosaletti K, Goodarzi AA, Petermann E, Concannon P et al. ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J 2006; 25: 5775–5782.

    Article  CAS  Google Scholar 

  10. Smith J, Tho LM, Xu N, Gillespie DA . The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res 2010; 108: 73–112.

    Article  CAS  Google Scholar 

  11. Dodson H, Bourke E, Jeffers LJ, Vagnarelli P, Sonoda E, Takeda S et al. Centrosome amplification induced by DNA damage occurs during a prolonged G2 phase and involves ATM. EMBO J 2004; 23: 3864–3873.

    Article  CAS  Google Scholar 

  12. Bozulic L, Surucu B, Hynx D, Hemmings BA . PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. Mol Cell 2008; 30: 203–213.

    Article  CAS  Google Scholar 

  13. Collis SJ, DeWeese TL, Jeggo PA, Parker AR . The life and death of DNA-PK. Oncogene 2005; 24: 949–961.

    Article  CAS  Google Scholar 

  14. Zou L, Elledge SJ . Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 2003; 300: 1542–1548.

    Article  CAS  Google Scholar 

  15. Bourke E, Brown JA, Takeda S, Hochegger H, Morrison CG . DNA damage induces Chk1-dependent threonine-160 phosphorylation and activation of Cdk2. Oncogene 2010; 29: 616–624.

    Article  CAS  Google Scholar 

  16. Robinson HM, Black EJ, Brown R, Gillespie DA . DNA mismatch repair and Chk1-dependent centrosome amplification in response to DNA alkylation damage. Cell Cycle 2007; 6: 982–992.

    Article  CAS  Google Scholar 

  17. Wang CY, Kao YH, Lai PY, Chen WY, Chung BC . Steroidogenic factor-1 (NR5A1) maintains centrosome homeostasis in steroidogenic cells by restricting centrosomal DNA-PK activation. Mol Cell Biol 2013; 33: 476–484.

    Article  CAS  Google Scholar 

  18. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K et al. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev 2000; 14: 1448–1459.

    Article  CAS  Google Scholar 

  19. Nakagawa Y, Yamane Y, Okanoue T, Tsukita S, Tsukita S . Outer dense fiber 2 is a widespread centrosome scaffold component preferentially associated with mother centrioles: its identification from isolated centrosomes. Mol Biol Cell 2001; 12: 1687–1697.

    Article  CAS  Google Scholar 

  20. Lee KJ, Lin YF, Chou HY, Yajima H, Fattah KR, Lee SC et al. Involvement of DNA-dependent protein kinase in normal cell cycle progression through mitosis. J Biol Chem 2011; 286: 12796–12802.

    Article  CAS  Google Scholar 

  21. Stolz A, Ertych N, Kienitz A, Vogel C, Schneider V, Fritz B et al. The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells. Nat Cell Biol 2010; 12: 492–499.

    Article  CAS  Google Scholar 

  22. Shang ZF, Huang B, Xu QZ, Zhang SM, Fan R, Liu XD et al. Inactivation of DNA-dependent protein kinase leads to spindle disruption and mitotic catastrophe with attenuated checkpoint protein 2 Phosphorylation in response to DNA damage. Cancer Res 2010; 70: 3657–3666.

    Article  CAS  Google Scholar 

  23. Golan A, Pick E, Tsvetkov L, Nadler Y, Kluger H, Stern DF . Centrosomal Chk2 in DNA damage responses and cell cycle progression. Cell Cycle 2010; 9: 2647–2656.

    Article  CAS  Google Scholar 

  24. Tsvetkov L, Xu X, Li J, Stern DF . Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody. J Biol Chem 2003; 278: 8468–8475.

    Article  CAS  Google Scholar 

  25. Joo K, Kim CG, Lee MS, Moon HY, Lee SH, Kim MJ et al. CCDC41 is required for ciliary vesicle docking to the mother centriole. Proc Natl Acad Sci USA 2013; 110: 5987–5992.

    Article  CAS  Google Scholar 

  26. Graser S, Stierhof YD, Lavoie SB, Gassner OS, Lamla S, Le Clech M et al. Cep164, a novel centriole appendage protein required for primary cilium formation. J Cell Biol 2007; 179: 321–330.

    Article  CAS  Google Scholar 

  27. An J, Yang DY, Xu QZ, Zhang SM, Huo YY, Shang ZF et al. DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein. Mol Cancer 2008; 7: 32.

    Article  Google Scholar 

  28. Ayene IS, Ford LP, Koch CJ . Ku protein targeting by Ku70 small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and gamma radiation. Mol Cancer Ther 2005; 4: 529–536.

    Article  CAS  Google Scholar 

  29. Rampakakis E, Di Paola D, Zannis-Hadjopoulos M . Ku is involved in cell growth DNA replication and G1-S transition. J Cell Sci 2008; 121: 590–600.

    Article  CAS  Google Scholar 

  30. Andreassen PR, D'Andrea AD, Taniguchi T . ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev 2004; 18: 1958–1963.

    Article  CAS  Google Scholar 

  31. Kramer A, Mailand N, Lukas C, Syljuasen RG, Wilkinson CJ, Nigg EA et al. Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase. Nat Cell Biol 2004; 6: 884–891.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank Ya-Min Lin for technical assistance in FACS analysis. This study was supported by grants from Academia Sinica, NHRI-EX102-10210SI and NSC102-2923-B-001-003-MY3 to B-cC and NSC102-2320-B-006–051 to C-YW.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B-c Chung.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, CY., Huang, EH., Huang, Sc. et al. DNA-PK/Chk2 induces centrosome amplification during prolonged replication stress. Oncogene 34, 1263–1269 (2015). https://doi.org/10.1038/onc.2014.74

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2014.74

This article is cited by

Search

Quick links